| 0 (0%) | 05-19 12:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 9.9  |
1-year : | 10.75 |
| Resists | First : | 8.48 |
Second : | 9.21 |
| Pivot price | 7.89 |
|||
| Supports | First : | 7.3 | Second : | 6.07 |
| MAs | MA(5) : | 7.49 |
MA(20) : | 8.12 |
| MA(100) : | 8.39 |
MA(250) : | 8.77 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 11.5 |
D(3) : | 10.7 |
| RSI | RSI(14): 37.2 |
|||
| 52-week | High : | 12.67 | Low : | 6.3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BAK ] has closed above bottom band by 33.4%. Bollinger Bands are 2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.63 - 7.67 | 7.67 - 7.7 |
| Low: | 7.44 - 7.48 | 7.48 - 7.51 |
| Close: | 7.49 - 7.54 | 7.54 - 7.59 |
Wed, 15 May 2024
Activision Blizzard quarterly net revenue 2023 - Statista
Wed, 15 May 2024
Activision Blizzard revenue by platform 2022 - Statista
Sat, 06 Apr 2024
Rumor: Back catalog ABK games announcement "gearing up" - XboxEra
Thu, 28 Mar 2024
Innovative yttrium-90 radioisotopes revolutionize liver cancer treatment // Show Me Mizzou // University of Missouri - University of Missouri
Wed, 06 Dec 2023
ABK obtains breakthrough designation for microspheres device - Medical Device Network
Tue, 05 Dec 2023
ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation ... - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 398 (M) |
| Shares Float | 203 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 3.3 (%) |
| Shares Short | 1,600 (K) |
| Shares Short P.Month | 1,940 (K) |
| EPS | -2.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.01 |
| Profit Margin | -6.5 % |
| Operating Margin | 16.1 % |
| Return on Assets (ttm) | -0.3 % |
| Return on Equity (ttm) | -104.2 % |
| Qtrly Rev. Growth | -12.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 177.09 |
| EBITDA (p.s.) | 8.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2,270 (M) |
| Levered Free Cash Flow | -666 (M) |
| PE Ratio | -3.34 |
| PEG Ratio | 0 |
| Price to Book value | 1.5 |
| Price to Sales | 0.04 |
| Price to Cash Flow | -1.33 |
| Dividend | 2.71 |
| Forward Dividend | 0 |
| Dividend Yield | 35.9% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|